Who We Are
- Cambridge University Press at a Glance
- Cambridge's Ethics
- The Press Syndicate
- The Press Board
- History of the Press
- The Queen's Printer's Patent
- Annual Report
- UK Gender Pay Gap 2020
- What We Do
- Environment & Community
- Rights & Permissions
- Our Bookshop
- Contact Us
- Legal Notices
- Annual Report
- Commitment to change
Open access future for European Psychiatry
European Psychiatry – the official journal of the European Psychiatric Association (EPA) – is to become fully open access in 2020.
The announcement coincides with that of the journal’s move to Cambridge University Press and means anyone will be able to read the research it publishes online and free of charge.
European Psychiatry supports the EPA’s mission to improve the lives of patients with psychiatric disorders and to promote professional excellence through education and research. Already a hybrid journal – publishing both open access and subscription-only articles – its move to Cambridge in January 2020 will see it become fully open access to better further that mission.
Philip Gorwood, EPA President, said: “Converting to open access, that is, providing free online access to all articles of European Psychiatry for everyone, as well as expanding article reuse rights, appeared a vital move to ensure that a maximum of psychiatrists and clinicians in Europe, and around the world, have access to important new findings.
“It is also of utmost importance to EPA, in light of its engagement with patient organisations, that patients and care givers be given the same opportunities. Partnering with Cambridge University Press will enable those goals while maintaining an accessible article processing charge for authors, and additional benefits for Association members.
“We also hope, and believe, that our partnership with Cambridge will further strengthen the EPA’s role as a leader in supporting and promoting psychiatric clinicians and researchers worldwide.”
The journal contains articles on topics relevant to all mental health clinicians, researchers and neuroscientists. These include original research on pre-clinical and clinical scientific fields investigating the aetiology, pathophysiology and treatment of major psychiatric disorders.
In a statement, the Editors-in-Chief of the journal underscored the journal’s commitment to accessibility and transparency that is fully aligned with international initiatives such as Plan S.
Ann Avouris, Publisher at Cambridge University Press, said: “We are delighted to partner with the EPA as they embrace open access, demonstrating their commitment to the open research movement as well as, practically, supporting their communities in responding to developments such as Plan S.
"Open access can be an opportunity for even greater impact and a way to support authors by increasing the reach and influence of their work. Cambridge’s Read and Publish strategy – as well as our focus on editorial development and creative marketing – will provide full support to the journal and its authors through this transition.”
She added: “As a university press and a part of the academic community, we are committed to help shape a sustainable, responsible open access future.